Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114867) titled 'A Real-World Study of Nefecon in the Treatment of IgA Nephropathy After Kidney Transplantation' on Dec. 18, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai Changhai Hospital
Condition:
IgA Nephropathy After Kidney Transplantation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-18
Target Sample Size: Nefecon treatment group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300619
Published by HT Digital Content Services with permission from Health Daily Digest....